PDC and fatty liver disease: A systemic increase in PDC activity in various tissues (heart, liver, muscle and kidney) by IP dosing of DCA (250 mg/kg/day) for two weeks also led to reduced hepatic steatosis relative to vehicle-treated controls (Supplementary Figure 4H).